Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship in Pediatric Neuropsychiatry, Psychiatry, University of North Carolina at Chapel Hill School of Medicine 1993 - 1994
  • Fellowship in Child and Adolescent Psychiatry, Psychiatry, University of North Carolina at Chapel Hill School of Medicine 1991 - 1993
  • General Psychiatry Residency, Psychiatry, University of North Carolina at Chapel Hill School of Medicine 1988 - 1992
  • M.D., University of Rochester School of Medicine and Denistry 1988
• Publications & Artistic Works
• 

  Selected Publications

  • Conference Papers

    • Jarskog, FF, Grove, RA, McEvoy, JP, Keefe, RSE, Lowy, MT, Horrigan, JP, and Peykamian, MA. "Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy." April 15, 2012.  Link to Item

  • Journal Articles

    • Anagnostou, E, Jones, N, Huerta, M, Halladay, AK, Wang, P, Scahill, L, Horrigan, JP, Kasari, C, Lord, C, Choi, D, Sullivan, K, and Dawson, G. "Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder." Autism : the International Journal of Research and Practice 19, no. 5 (July 2015): 622-636. (Review)  Full Text
    • Jarskog, LF, Lowy, MT, Grove, RA, Keefe, RSE, Horrigan, JP, Ball, MP, Breier, A, Buchanan, RW, Carter, CS, Csernansky, JG, Goff, DC, Green, MF, Kantrowitz, JT, Keshavan, MS, Laurelle, M, Lieberman, JA, Marder, SR, Maruff, P, McMahon, RP, Seidman, LJ, and Peykamian, MA. "A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy." Schizophrenia research 164, no. 1-3 (May 2015): 136-142.  Full Text
    • Jarskog, LF, Lowy, MT, Grove, RA, Keefe, RSE, Horrigan, JP, Ball, MP, Breier, A, Buchanan, RW, Carter, CS, Csernansky, JG, Goff, DC, Green, MF, Kantrowitz, JT, Keshavan, MS, Laurelle, M, Lieberman, JA, Marder, SR, Maruff, P, McMahon, RP, Seidman, LJ, and Peykamian, MA. "A Phase II study of a histamine H<inf>3</inf> receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy." Schizophrenia Research 164, no. 1-3 (January 1, 2015): 136-142.  Full Text
    • Scahill, L, Aman, MG, Lecavalier, L, Halladay, AK, Bishop, SL, Bodfish, JW, Grondhuis, S, Jones, N, Horrigan, JP, Cook, EH, Handen, BL, King, BH, Pearson, DA, McCracken, JT, Sullivan, KA, and Dawson, G. "Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder." Autism : the International Journal of Research and Practice 19, no. 1 (January 2015): 38-52. (Review)  Full Text
    • Lecavalier, L, Wood, JJ, Halladay, AK, Jones, NE, Aman, MG, Cook, EH, Handen, BL, King, BH, Pearson, DA, Hallett, V, Sullivan, KA, Grondhuis, S, Bishop, SL, Horrigan, JP, Dawson, G, and Scahill, L. "Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder." Journal of Autism and Developmental Disorders 44, no. 5 (May 2014): 1128-1143. (Review)  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.